Literature DB >> 19259279

Biological imaging in the assessment of neoadjuvant treatment response in esophageal cancer: a new era?

John Th Plukker1.   

Abstract

Entities:  

Year:  2008        PMID： 19259279      PMCID： PMC2632562     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  17 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Surgery after primary chemoradiotherapy in squamous cancer of the esophagus: is the photon mightier than the sword?

Authors:  David H Ilson
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

3.  Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy.

Authors:  B D Beseth; R Bedford; W H Isacoff; E C Holmes; R B Cameron
Journal:  Am Surg       Date:  2000-09       Impact factor: 0.688

4.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Authors:  Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck Bonnetain; Christine Binquet
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

5.  Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma.

Authors:  Joseph Willis; Gregory S Cooper; Gerard Isenberg; Michael V Sivak; Nathan Levitan; Julie Clayman; Amitabh Chak
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

6.  Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.

Authors:  Henderik L van Westreenen; David C P Cobben; Pieter L Jager; Hendrik M van Dullemen; Jelle Wesseling; Philip H Elsinga; John Th Plukker
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

Review 7.  PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.

Authors:  Lale Kostakoglu; Stanley J Goldsmith
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

8.  Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

Authors:  Jeffrey L Port; Paul C Lee; Robert J Korst; Yaakov Liss; Danish Meherally; Paul Christos; Madhu Mazumdar; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

9.  The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.

Authors:  Katja Ott; Ken Herrmann; Bernd-Joachim Krause; Florian Lordick
Journal:  Gastrointest Cancer Res       Date:  2008-11

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.